Ernexa Therapeutics, Inc. (ERNA)
12.46
+1.06
(+9.30%)
USD |
NASDAQ |
May 21, 16:00
12.42
-0.04
(-0.32%)
After-Hours: 07:33
Ernexa Therapeutics Total Liabilities (Quarterly) : 3.684M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Quince Therapeutics, Inc. | 10.95M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Tango Therapeutics, Inc. | 44.29M |
| Aprea Therapeutics, Inc. | 5.297M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.54M |
| Shareholders Equity (Quarterly) | 6.859M |
| Debt to Equity Ratio | 0.0567 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 1.02% |